Data / Form D filings / VENTRUS BIOSCIENCES INC
VENTRUS BIOSCIENCES INC: Form D filings
VENTRUS BIOSCIENCES INC, a biotechnology company in New York, NY, filed 3 Form D notices with the SEC in 2010. The latest, on May 24, 2010, reports $700,000 sold of a $750,000 offering to 8 investors.
Find out what VENTRUS BIOSCIENCES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 787 7TH AVENUE, 48TH FLOOR, New York, NY, 10019
- Phone
- (212) 554-4388
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2005
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1426800
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 24, 2010 | New notice | $750,000 | $700,000 | $50,000 | 8 | May 6, 2010 | sec.gov |
| Apr 26, 2010 | Amendment | $4,500,000 | $2,725,000 | $1,775,000 | 44 | Feb 26, 2010 | sec.gov |
| Mar 12, 2010 | New notice | $4,500,000 | $2,150,000 | $2,350,000 | 35 | Feb 26, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Felder | Director | |
| Thom Rowland | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of May 24, 2010 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VENTRUS BIOSCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.